Analysis of the potential biological value of pyruvate dehydrogenase E1 subunit β in human cancer

Figure 8 Correlation of pyruvate dehydrogenase E1 subunit β gene expression with stromal and immune scores in different cancers. A: Correlation analysis of pyruvate dehydrogenase E1 subunit β (PDHB) gene expression with immune scores of bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), brain lower grade glioma (LGG), lung adenocarcinoma (LUAD), lung squamous cell carcinoma, pancreatic adenocarcinoma (PAAD), thyroid carcinoma (THCA), uterine corpus endometrial carcinoma (UCEC); B: Correlation analysis of PDHB gene expression with stromal scores of BLCA, BRCA, LGG, liver hepatocellular carcinoma, LUAD, mesothelioma, ovarian serous cystadenocarcinoma, PAAD, prostate adenocarcinoma, sarcoma, testicular germ cell tumors, THCA, thymoma, UCEC. ^aP < 0.05, ^bP < 0.01, ^cP < 0.001. BRCA: Breast invasive carcinoma; BLCA: Bladder urothelial carcinoma; LGG: Brain lower grade glioma; LUAD: Lung adenocarcinoma; LUSC: Lung squamous cell carcinoma; PAAD: Pancreatic adenocarcinoma; THCA: Thyroid carcinoma; UCEC: Uterine corpus endometrial carcinoma; BRCA: Breast invasive carcinoma; LIHC: Liver hepatocellular carcinoma; MESO: Mesothelioma; OV: Ovarian serous cystadenocarcinoma; PRAD: Prostate adenocarcinoma; SARC: Sarcoma; TGCT: Testicular germ cell tumors; THCA: Thyroid carcinoma; THYM: Thymoma; UCEC: Uterine corpus endometrial carcinoma.